Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 7 posts of 262 posts found.

Bayer boosted by Schering integration

March 4, 2009
Sales and Marketing Bayer

Profits at Bayer's healthcare division rose by 10% to 4.1 billion euros last year as it increasingly felt the benefits …

News

Chinese move marks ‘globalisation’ of Bayer Schering R&D

March 2, 2009
Research and Development Asia, Bayer, China

Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …

News

Bayer’s cardiovascular drug enters phase III

February 13, 2009
Research and Development, Sales and Marketing Bayer, cv

Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …

News

Contraceptive and Betaferon sales bolster Bayer

October 30, 2008
Sales and Marketing Bayer

Strong sales of Bayer's Yaz contraceptives and multiple sclerosis treatment Betaferon have helped third quarter pharma sales that could only …

News

The Pharmafocus Interview: Martin Dawkins

September 4, 2008
Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare

 Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …

Feature

Bayer Schering blood clotting drug a ‘major leap forward’

December 14, 2007
Sales and Marketing Bayer, Xarelto, clot

Bayer Schering says its new blood clotting drug Xarelto is poised to set a new standard of care for post-surgery …

News

Bayer’s Nexavar and Xarelto key to future growth

November 9, 2007
Sales and Marketing Bayer, Xarelto

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025